North America Immune Checkpoint Inhibitors Market Size, Share & Industry Trends Analysis Report By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma, and others), By Type, By Country and Growth Forecast, 2021 - 2027

TABLE 1 North America Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 2 North America Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Immune Checkpoint Inhibitors Market
TABLE 4 Acquisition and Mergers– Immune Checkpoint Inhibitors Market
TABLE 5 Approvals and Trials– Immune Checkpoint Inhibitors Market
TABLE 6 North America Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 7 North America Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 8 North America Lung Cancer Market by Country, 2017 - 2020, USD Million
TABLE 9 North America Lung Cancer Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Bladder Cancer Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Bladder Cancer Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Melanoma Market by Country, 2017 - 2020, USD Million
TABLE 13 North America Melanoma Market by Country, 2021 - 2027, USD Million
TABLE 14 North America Hodgkin lymphoma Market by Country, 2017 - 2020, USD Million
TABLE 15 North America Hodgkin lymphoma Market by Country, 2021 - 2027, USD Million
TABLE 16 North America Other Application Market by Country, 2017 - 2020, USD Million
TABLE 17 North America Other Application Market by Country, 2021 - 2027, USD Million
TABLE 18 North America Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 19 North America Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 20 North America PD-1 Inhibitor Market by Country, 2017 - 2020, USD Million
TABLE 21 North America PD-1 Inhibitor Market by Country, 2021 - 2027, USD Million
TABLE 22 North America PD-L1 Inhibitor Market by Country, 2017 - 2020, USD Million
TABLE 23 North America PD-L1 Inhibitor Market by Country, 2021 - 2027, USD Million
TABLE 24 North America CTLA-4 Inhibitor Market by Country, 2017 - 2020, USD Million
TABLE 25 North America CTLA-4 Inhibitor Market by Country, 2021 - 2027, USD Million
TABLE 26 North America Immune Checkpoint Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 27 North America Immune Checkpoint Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 28 US Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 29 US Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 30 US Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 31 US Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 32 US Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 33 US Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 34 Canada Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 35 Canada Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 36 Canada Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 37 Canada Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 38 Canada Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 39 Canada Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 40 Mexico Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 41 Mexico Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 42 Mexico Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 43 Mexico Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 44 Mexico Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 45 Mexico Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 46 Rest of North America Immune Checkpoint Inhibitors Market, 2017 - 2020, USD Million
TABLE 47 Rest of North America Immune Checkpoint Inhibitors Market, 2021 - 2027, USD Million
TABLE 48 Rest of North America Immune Checkpoint Inhibitors Market by Application, 2017 - 2020, USD Million
TABLE 49 Rest of North America Immune Checkpoint Inhibitors Market by Application, 2021 - 2027, USD Million
TABLE 50 Rest of North America Immune Checkpoint Inhibitors Market by Type, 2017 - 2020, USD Million
TABLE 51 Rest of North America Immune Checkpoint Inhibitors Market by Type, 2021 - 2027, USD Million
TABLE 52 KEY INFORMATION – ASTRAZENECA PLC
TABLE 53 KEY INFORMATION – BEIGENE LTD.
TABLE 54 KEY INFORMATION – SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
TABLE 55 KEY INFORMATION – BRISTOL MYERS SQUIBB COMPANY
TABLE 56 KEY INFORMATION – GLAXOSMITHKLINE PLC
TABLE 57 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 58 KEY INFORMATION – MERCK GROUP
TABLE 59 KEY INFORMATION – SANOFI S.A.
TABLE 60 KEY INFORMATION - MERCK & CO., INC.
TABLE 61 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, May – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: Sanofi s.a.